Hodgson, J <br/><br/>
Bayer lapse exposes pharma's vulnerability.  [electronic resource] 

 -  Nature biotechnology  Oct 2001 
 - 897-8 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1087-0156 
<br/><br/><label>Standard No.: </label>10.1038/nbt1001-897b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anticholesteremic Agents--adverse effects<br/>Drug Industry<br/>Humans<br/>Product Surveillance, Postmarketing<br/>Pyridines--adverse effects<br/>Research<br/>Rhabdomyoma--chemically induced